Reducing the Diagnosis of Infectious Diseases to Minutes, In Any Setting Anywhere

Our Technology Was Developed at the University of Minnesota and Is Patented Worldwide

  • doc-eye2

    It provides definitive, enhanced-sensitivity point-of-care (POC) diagnostic results, whether in physicians' offices, consumers’ homes, workplaces, or any location.

  • docs

    Now, clinicians, caregivers and even consumers will be able to get immediate diagnosis for diseases such as Malaria, Influenza, Strep, STIs, HIV, COVID-19, and more.

  • ambulance

    Meaning faster clinical action assessments and coordination of care for immediate treatment, improving quality of care and saving considerable time and money.

  • op-room

    Our technology greatly reduces false negatives, eliminating the need for confirmatory testing, speeding treatment, and reducing healthcare costs.

  • workflow

    What’s more, it requires no change for users to their diagnostic test workflow.

  • couple-crowd

    The ultimate benefit is a substantial reduction in the economic burden of infectious diseases on society.

Learn More |

Vigilant Diagnostics, LLC is a University of Minnesota Office for Technology Commercialization startup.